Caroline Alves Feitosa

Caroline Alves Feitosa

Auto-generated profile, based on publicly available information

Caroline Alves Feitosa

Bahiana School of Medicine and Public Health Salvador Bahia Brazil

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2024 in Tropical Medicine & International Health
Verified
Journal Article
Closed access
VPVictoria Cruz Paraná
Victoria Cruz Paraná
CFCaroline Alves Feitosa
Caroline Alves Feitosa
GSGreice Carolina Santos da Silva
Greice Carolina Santos da Silva
LGLuana Leandro Gois
Luana Leandro Gois
LSLuciane Amorim Santos
Luciane Amorim Santos

30 January 2018 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Open access
LMLara Evellyn Do Macedo
Lara Evellyn Do Macedo
VFViviane Matos Ferreira
Viviane Matos Ferreira
CFCaroline Alves Feitosa
Caroline Alves Feitosa
ANAmélia Maria Pithon Borges Nunes
Amélia Maria Pithon Borges Nunes
LCLeila Campos
Leila Campos
MSMarco Aurelio Palazzi Safadi
Marco Aurelio Palazzi Safadi
The significant increase in the incidence rates and ongoing outbreaks of serogroup C meningococcal (MenC) disease, associated with the sequence type-103 complex, motivated the incorporation of the meningococcal C conjugate (MCC) vaccine in the routine immunization program in the State of Bahia, Brazil in early 2010, targeting children younger than 5 years of age. In its capital, Salvador, the program also included a catch-up campaign for individuals 10–24 years of age. We performed an observational, ecological study, analyzing data collected from 2007 to 2015, to compare the impact of these two immunization strategies on meningococcal disease incidence and mortality rates. In Salvador, following the vaccination program, a dramatic early impact on MenC disease and mortality rates could be observed, with significant reductions in incidence rates of MenC disease in all age groups, including individuals that were too old to have been vaccinated, indicating the presence of herd protection. Compared to the pre-vaccine period, a virtual disappearance of MenC disease was observed in 2015. However, in the state of Bahia (excluding the city of Salvador), no herd protection could be observed, with significant impact only among vaccine-eligible children within 5 years of introduction of the MCC vaccination program. These results highlight the importance of catch-up campaigns, including adolescents and young adults, to induce herd protection compared to immunization strategies restricted to infants and young children. This information is crucial for identifying optimal immunization policies and future strategies, focused on adolescents, to optimize the impact of MCC vaccination programs.